|
1
|
Tu L, Su P, Zhang Z, Gao L, Wang J, Hu T,
Zhou J, Zhang Y, Zhao Y, Liu Y, et al: Genome of tripterygium
wilfordii and identification of cytochrome P450 involved in
triptolide biosynthesis. Nat Commun. 11(971)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cai A, Qi S, Su Z, Shen H, Ma W and Dai Y:
Tripterygium glycosides inhibit inflammatory mediators in the rat
synovial RSC-364 cell line stimulated with interleukin-1β. Biomed
Rep. 3:763–766. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cui J, Chen X and Su J: Advanced progress
of main pharmacology activities of triptolide. Zhongguo Zhong Yao
Za Zhi. 42:2655–2658. 2017.(In Chinese). PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wang J, Chu Y and Zhou X: Inhibitory
effect of triperygium wilfordii polyglucoside on dipeptidyl
peptidase I in vivo and in vitro. Biomed Pharmacother. 96:466–470.
2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Fan D, Guo Q, Shen J, Zheng K, Lu C, Zhang
G, Lu A and He X: The effect of triptolide in rheumatoid arthritis:
From basic research towards clinical translation. Int J Mol Sci.
19(376)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gu Y, Yang M, Tang X, Wang T, Yang D, Zhai
G and Liu J: Lipid nanoparticles loading triptolide for transdermal
delivery: Mechanisms of penetration enhancement and transport
properties. J Nanobiotechnology. 16(68)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shan Q, Jiang X, Wang F, Shu Z and Gui S:
Cubic and hexagonal liquid crystals as drug carriers for the
transdermal delivery of triptolide. Drug Deliv. 26:490–498.
2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang L, Chang J, Zhao Y, Xu H, Wang T, Li
Q, Xing L, Huang J, Wang Y and Liang Q: Fabrication of a
triptolide-loaded and poly-γ-glutamic acid-based amphiphilic
nanoparticle for the treatment of rheumatoid arthritis. Int J
Nanomedicine. 13:2051–2064. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhao Y, Guan Y, Le X, Zhu W and Chen L:
Experimental research on acute toxicity and skin irritation of
triptolide microemulsion gel. Shanghai Chin Med J. 44:75–77.
2010.
|
|
10
|
Mathew S and Abraham TE: Bioconversions of
ferulic acid, an hydroxycinnamic acid. Crit Rev Microbiol.
32:115–125. 2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ganesan R and Rasool M: Ferulic acid
inhibits interleukin 17-dependent expression of nodal pathogenic
mediators in fibroblast-like synoviocytes of rheumatoid arthritis.
J Cell Biochem: Aug 30, 2018 (Epub ahead of print). doi:
10.1002/jcb.27502. 2018.
|
|
12
|
Sgarbossa A, Giacomazza D and Di Carlo M:
Ferulic acid: A hope for Alzheimer's disease therapy from plants.
Nutrients. 7:5764–5782. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tao L, Xiao F, Zhu W, Chen L, Guan Y, Jin
C and Wu L: Attenuation effect of tripterygii Radix et Rhizoma.
Chin J Exp Trad Med For. 23:230–234. 2017.(In Chinese).
|
|
14
|
Tao L, Guan Y, Chen L, Xiao F, Jin C and
Zang Z: Research progress on detoxicity by tripterygii Radix et
Rhizoma compatibility. Chin J Exp Trad Med For. 24:2292018.(In
Chinese).
|
|
15
|
Guan Y, Tao L, Xiao F, Chen L, Zhu Y, Jin
C and Zang Z: Prescription rules of preparations containing
tripterygium wilfordii Hook.f.against rheumatoid arthritis. Chin J
Hosp Pharm. 38:64–68. 2018.(In Chinese).
|
|
16
|
Park JH, Lee JE, Choi SS and Park TH:
Protective effects of silkworm hemolymph extract and its fractions
on UV-induced photoaging. Biotechnol Bioprocess Engineering.
22:37–44. 2017.
|
|
17
|
Farrar MD, Nicolaou A, Clarke KA, Mason S,
Massey KA, Dew TP, Watson RE, Williamson G and Rhodes LE: A
randomized controlled trial of green tea catechins in protection
against ultraviolet radiation-induced cutaneous inflammation. Am J
Clin Nutr. 102:608–615. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Narasaiah UL: Antioxidants and Human
Diseases. In: Clinica Chimica Acta. PubMed, p16, 2014.
|
|
19
|
Swanson HI: Cytochrome P450 expression in
human keratinocytes: An aryl hydrocarbon receptor perspective. Chem
Biol Interact. 149:69–79. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Smith G, Wolf CR, Deeni YY, Dawe RS, Evans
AT, Comrie MM, Ferguson J and Ibbotson SH: Cutaneous expression of
cytochrome P450 CYP2S1: Individuality in regulation by therapeutic
agents for psoriasis and other skin diseases. Lancet.
361:1336–1343. 2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Chopra D, Ray L, Dwivedi A, Tiwari SK,
Singh J, Singh KP, Kushwaha HN, Jahan S, Pandey A, Gupta SK, et al:
Photoprotective efficiency of PLGA-curcumin nanoparticles versus
curcumin through the involvement of ERK/AKT pathway under ambient
UV-R exposure in HaCaT cell line. Biomaterials. 84:25–41.
2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fabian E, Vogel D, Blatz V, Ramirez T,
Kolle S, Eltze T, van Ravenzwaay B, Oesch F and Landsiedel R:
Xenobiotic metabolizing enzyme activities in cells used for testing
skin sensitization in vitro. Arch Toxicol. 87:1683–1696.
2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bi YF, Zheng Z, Pi ZF, Liu ZQ and Song FR:
The metabolic fingerprint of the compatibility of Radix Aconite and
Radix Paeoniae Alba and its effect on CYP450 enzymes. Yao Xue Xue
Bao. 49:1705–1710. 2014.(In Chinese). PubMed/NCBI
|
|
24
|
Liao HW, Chen GY, Wu MS, Liao WC, Tsai IL
and Kuo CH: Quantification of endogenous metabolites by the
postcolumn infused-internal standard method combined with matrix
normalization factor in liquid chromatography-electrospray
ionization tandem mass spectrometry. J Chromatogr A. 1375:62–68.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Liu JQ, Li Q, Zhang R, Liu F, Zhang W, He
ZH, Hong Q, Kou XL and Wu JM: LC-MS/MS studies on effect of
Glycyrrhiza uralensis on metabolism, distribution and
excretion of triptolide in rat. Chin J Pharm Anal. 30:1664–1671.
2010.
|
|
26
|
Huang QX, Lei HH, Tang HR and Wang YL:
Quantitative analysis of ceramides by ultrahigh-performance liquid
chromatography tandem mass spectrometry. Journal of Shanghai Jiao
Tong University. 39:1353–1359. 2019.
|
|
27
|
Eagling VA, Tjia JF and Back DJ:
Differential selectivity of cytochrome P450 inhibitors against
probe substrates in human and rat liver microsomes. Br J Clin
Pharmacol. 45:107–114. 1998.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liu A, Qi X, Zhang YC, Xu TX, Yi J and
Yang J: Principle and applications of fluorescent probes for
intracellular redox detection. J Shanghai Jiao Tong University
(Medical Edition). 38:101–107. 2018.
|
|
29
|
Chen XF: Current and future technological
advances in transdermal gene delivery. Adv Drug Deliv Rev.
127:85–105. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cui L, Jia Y, Cheng Z, Gao Y, Zhang G, Li
J and He C: Advancements in the maintenance of skin barrier/skin
lipid composition and the involvement of metabolic enzymes. J
Cosmet Dermatol. 15:549–558. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hou CS, Yang ZH and Sun XB: Progress of
‘cocktail’ probe substrates approach and its application in studies
of traditional Chinese materia medica on cytochrome P450 system.
Chin J Pharmacol Toxicol. 27:445–450. 2013.
|
|
32
|
De Andrés F, Terán S, Bovera M, Fariñas H,
Terán E and LLerena A: Multiplex phenotyping for systems medicine:
A one-point optimized practical sampling strategy for simultaneous
estimation of CYP1A2, CYP2C9, CYP2C19, and CYP2D6 activities using
a cocktail approach. Omics. 20:88–96. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Bi Y, Zheng Z, Pi Z, Liu Z and Song F: The
metabolic fingerprint of the compatibility of radix aconite and
radix paeoniae alba and its effect on CYP450 enzymes. Yao Xue Xue
Bao. 49:1705–1710. 2014.(In Chinese). PubMed/NCBI
|
|
34
|
Tai T, Huang X, Su Y, Ji J, Su Y, Jiang Z
and Zhang L: Glycyrrhizin accelerates the metabolism of triptolide
through induction of CYP3A in rats. J Ethnopharmacol. 152:358–363.
2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Xu Y, Zhang YF, Chen XY and Zhong DF:
CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics
of triptolide and its derivative in rats. Acta Pharmacol Sin.
39:1386–1392. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Martignoni M, Groothuis GM and de Kanter
R: Species differences between mouse, rat, dog, monkey and human
CYP-mediated drug metabolism, inhibition and induction. Expert Opin
Drug Metab Toxicol. 2:875–894. 2006.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Uno Y, Hosaka S, Matsuno K, Nakamura C,
Kito G, Kamataki T and Nagata R: Characterization of cynomolgus
monkey cytochrome P450 (CYP) cDNAs: Is CYP2C76 the only
monkey-specific CYP gene responsible for species differences in
drug metabolism? Arch Biochem Biophys. 466:98–105. 2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Heikkinen AT, Friedlein A, Matondo M,
Hatley OJ, Petsalo A, Juvonen R, Galetin A, Rostami-Hodjegan A,
Aebersold R, Lamerz J, et al: Quantitative ADME Proteomics-CYP and
UGT enzymes in the beagle dog liver and intestine. Pharm Res.
32:74–90. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Fujii H, Emoto M and Sato-Akaba H: Brain
redox imaging using in vivo electron paramagnetic resonance imaging
and nitroxide imaging probes. Magnetochemistry. 5(11)2019.
|
|
40
|
Volpe CM, Villar-Delfino PH, dos Anjos PM
and Nogueira-Machado JA: Cellular death, reactive oxygen species
(ROS) and diabetic complications. Cell Death Dis.
9(119)2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Labuschagne CF and Brenkman AB: Current
methods in quantifying ROS and oxidative damage in caenorhabditis
elegans and other model organism of aging. Ageing Res Rev.
12:918–930. 2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Poljsak B, Šuput D and Milisav I:
Achieving the balance between ROS and antioxidants: When to use the
synthetic antioxidants. Oxid Med Cell Longev.
2013(956792)2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Slatter DA, Bolton CH and Bailey AJ: The
importance of lipid-derived malondialdehyde in diabetes mellitus.
Diabetologia. 43:550–557. 2000.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Cacciatore I, Baldassarre L, Fornasari E,
Mollica A and Pinnen F: Recent advances in the treatment of
neurodegenerative diseases based on GSH delivery systems. Oxid Med
Cell Longev. 2012(240146)2012.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Shen SC, Lee WR, Yang LY, Tsai HH, Yang LL
and Chen YC: Quercetin enhancement of arsenic-induced apoptosis via
stimulating ROS-dependent p53 protein ubiquitination in human HaCaT
keratinocytes. Exp Dermatol. 21:370–375. 2012.PubMed/NCBI View Article : Google Scholar
|
|
46
|
He L, Tao L, Guan Y, Chen L, Zhu W, Jin C
and Wu L: Preparation and evaluation of triptolide and ferulic acid
ethosomes. Chin Tradit Herbal Drugs. 49:2817–2825. 2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Cao L, Li H, Yan M, Li Z, Gong H, Jiang P,
Deng Y, Fang P and Zhang B: The protective effects of
isoliquiritigenin and glycyrrhetinic acid against
triptolide-induced oxidative stress in HepG2 cells involve Nrf2
activation. Evid Based Complement Alternat Med.
2016(8912184)2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Vomund S, Schäfer A, Parnham M, Brüne B
and von Knethen A: Nrf2, the master regulator of anti-oxidative
responses. Int J Mol Sci. 18(2772)2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ishii T and Warabi E: Mechanism of rapid
nuclear factor-E2-related factor 2 (Nrf2) activation via
membrane-associated estrogen receptors: Roles of NADPH oxidase 1,
neutral sphingomyelinase 2 and epidermal growth factor receptor
(EGFR). Antioxidants (Basel). 8(69)2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Oyake T, Itoh K, Motohashi H, Hayashi N,
Hoshino H, Nishizawa M, Yamamoto M and Igarashi K: Bach proteins
belong to a novel family of BTB-basic leucine zipper transcription
factors that interact with MafK and regulate transcription through
the NF-E2 site. Mol Cell Biol. 16:6083–6095. 1996.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Gan L and Johnson JA: Oxidative damage and
the Nrf2-ARE pathway in neurodegenerative diseases. Biochim Biophys
Acta. 1842:1208–1218. 2014.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Tang W, Jiang YF, Ponnusamy M and Diallo
M: Role of Nrf2 in chronic liver disease. World J Gastroenterol.
20:13079–13087. 2014.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Wang Y, Guo SH, Shang XJ, Yu LS, Zhu JW,
Zhao A, Zhou YF, An GH, Zhang Q and Ma B: Triptolide induces
Sertoli cell apoptosis in mice via ROS/JNK-dependent activation of
the mitochondrial pathway and inhibition of Nrf2-mediated
antioxidant response. Acta Pharmacol Sin. 39:311–327. 2018.
|
